Healthcare | July 06, 2022
Apollo Hospitals integrates cardiovascular risk tool with ConnectedLife digital wellness solutions
The AICVD tool can predict the risk of cardiovascular disease.
The AICVD tool can predict the risk of cardiovascular disease.
Vaccizone’s ASC Technology is an enhanced antigen/bioactive delivery method based on Antigen Presenting Cells
The vaccine is under FDA review
Sanofi will begin to ship their vaccines helping to ensure more people will be immunized
Shanghai Public Health Clinical Center Completed the First Patient Dosing in Clinical Study of PD-L1 Antibody ASC22 in Combination with Chidamide for Functional Cure of HIV Infection
Submission seeks approval for the treatment of COVID-19 in both vaccinated and unvaccinated individuals at high risk
H Clinical is the leader in decentralized clinical trial support and home visits in Latin America
Analysis of Post-Marketing Safety Data Shows Consistent Findings with Safety Profile Reported in Clinical Trials of Edaravone
It is a two dose vaccine to be administered intramuscularly at 28 days apart
73% have cited fears like losing eyesight, painful procedure or long recovery period when it comes to cataract surgeries
Subscribe To Our Newsletter & Stay Updated
